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Background: Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder
sharing genetic risk factors with other common psychiatric disorders. However, intergenerational recurrence
patterns of ADHD from parents to sons and daughters are not known. We aimed to examine the risk of ADHD in
offspring of parents with ADHD and parents with other psychiatric disorders by parental and offspring sex, using
parents without the specific disorders as comparison. Methods: In a generation study linking data from several
population-based registries, all Norwegians born 1967–2011 (n = 2,486,088; Medical Birth Registry of Norway) and
their parents were followed to 2015. To estimate intergenerational recurrence risk, we calculated prevalence
differences (PD) and the relative risk (RR) of ADHD in offspring by parental ADHD, bipolar disorder (BD),
schizophrenia spectrum disorder (SCZ), major depression (MDD), all by parental and offspring sex. Results: The
absolute prevalence of ADHD in offspring of parents with ADHD was very high, especially in sons of two affected
parents (41.5% and 25.1% in sons and daughters, respectively), and far higher than in offspring of parents with BD,
SCZ or MDD. Intergenerational recurrence risks were higher for maternal than paternal ADHD (RRmaternal 8.4, 95%
confidence interval (CI) 8.2–8.6 vs. RRpaternal 6.2, 6.0–6.4) and this was also true on the absolute scale (PDmaternal
21.1% (20.5–21.7) vs. PDpaternal 14.8% (14.3–15.4)). RRs were higher in daughters, while PDs higher in sons. Parental
SCZ, BD and MDD were associated with an approximately doubled risk of offspring ADHD compared to parents
without the respective disorders, and estimates did not differ significantly between daughters and sons.
Conclusions: The intergenerational recurrence risks of ADHD were high and higher from mothers with ADHD than
fathers with ADHD. Other parental psychiatric disorders also conferred increased risk of offspring ADHD, but far
lower, indicating a sex- and diagnosis-specific intergenerational recurrence risk in parents with ADHD. Keywords:
Attention-deficit/hyperactivity disorder; intergenerational recurrence risk; parent-of-origin; epidemiology; sex
differences.
Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a
highly heritable neurodevelopmental disorder with
polygenic and environmental origins (Faraone &
Larsson, 2019; Pettersson, Lichtenstein, Lichten-
stein, Larsson, Song, & Polderman, 2019), and often
comorbid with other psychiatric disorders (Chen
et al., 2018; Solberg et al., 2018). Genetic studies
indicate that different genetic mechanisms con-
tribute to the risk of ADHD through rare and
common genetic variants, gene 9 environment inter-
actions, as well as by parent-of-origin effects (POE)
(Faraone & Larsson, 2019; Zayats, Johansson, &
Haavik, 2015). The term POE refers to maternal and
paternal genotypes not contributing equally to the
development of a phenotype in their offspring, thus
differentially influencing the heritability of ADHD
(Zayats et al., 2015). Several genetic mechanisms
could account for such differences in intergenera-
tional recurrence effects from mothers and fathers to
offspring; for example, genomic imprinting, effects of
the maternal genome on the intrauterine environ-
ment, mitochondrial genome and sex chromosomes
(Khramtsova, Davis, & Stranger, 2019). Further,
shared genetic (Doherty & Owen, 2014; Ruderfer
et al., 2014; The Brainstorm Consortium, 2018), and
environmental factors (Pettersson, Larsson,
D’Onofrio, Almqvist, & Lichtenstein, 2019) between
ADHD and other psychiatric disorders may also
contribute to the risk of ADHD in offspring when
parents have other psychiatric disorders (Rasic,
Hajek, Alda, & Uher, 2014).
In addition to the direct effect of transmitted alleles
from parents, nontransmitted alleles can act
through their impact on the pre- and postnatal
environment. This includes ‘genetic nurturing
effects’, that is, environmental effects with a genetic
component (Kong et al., 2018). Even if both parents
contribute to genetic nurture, maternal and paternalConflict of interest statement: See Acknowledgements for full
disclosures.
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effects can differ for different outcomes. Thus, Kong
and colleagues observed a stronger maternal than
paternal nurturing effect on health aspects of the
offspring, while both parents contributed similarly
on educational attainment (Kong et al., 2018).
It has been shown that in ~50% of families where
one child had been diagnosed with ADHD, at least
one parent had ADHD (Smalley et al., 2000;
Takeda et al., 2010). Another clinical study showed
that children received higher ratings of ADHD if
mothers had a history of ADHD than if fathers had
a history of ADHD (Goos, Ezzatian, & Schachar,
2007), whereas a family study showed that both
mothers’ and fathers’ ADHD equally increased the
risk of ADHD in offspring (Thissen, Rommelse,
Altink, Oosterlaan, & Buitelaar, 2014). We have
not found any studies investigating the role of
offspring sex in intergenerational ADHD recurrence
risk. Further, the mentioned studies are small and
originate from a time when parents were not likely
to be diagnosed with ADHD as adults, and none of
the studies have been population-based, thus
vulnerable to bias related to missing information.
Moreover, relatively little is known about the asso-
ciations between other parental psychiatric disor-
ders and offspring ADHD.
Therefore, our overall aim was to examine inter-
generational recurrence risk of ADHD, and risk of
ADHD in offspring of parents with other psychiatric
disorders within an epidemiological framework,
including an evaluation of parent-of-origin effects
and the role of offspring sex. Such data can provide
new information about ADHD transmission,
increase etiological understanding, and provide risk
estimates that could prove helpful in diagnosis and
clinical management of ADHD.
Methods and measures
The registries
We linked multiple nationwide, population-based
registries in Norway, all with compulsory notifica-
tion: The Medical Birth Registry of Norway (MBRN),
established in 1967 (Irgens, 2000), the Norwegian
Prescription Database (NorPD) established in 2004
(Furu et al., 2010), the Norwegian Patient Registry
(NPR) with linkable data from 2008 (Nesvag et al.,
2017), and the National Educational Database
(NUDB) from Statistics Norway (Steingrimsdottir
et al., 2012), (Appendix S1 for details). A unique
national identification number made it possible to
link individual records from the registries. The study
was approved by the Regional Committees for Med-
ical Research Ethics in Norway (2011/2272), and
reported according to guidelines suggested by the
Strengthening the Reporting of Observational Stud-
ies in Epidemiology (STROBE) Initiative (von Elm
et al., 2007).
Inclusions/exclusions and exposure definitions
We included individuals registered as births in the
MBRN during 1967–2011 and alive at record linkage
in 2015. We used biological sex as assigned at birth.
Individuals (both parents and offspring) who were
dispensed ADHD medication (methylphenidate,
racemic amphetamine, dexamphetamine or atomox-
etine) at any time during 2004–2015 (NorPD), or had
received a diagnosis of ADHD or hyperkinetic disor-
der (International Classification of Diseases (ICD-10)
code F90) in the NPR during 2008–2015 were defined
as ‘having ADHD’. Individuals prescribed central
stimulants for narcolepsy were excluded from the
ADHD definition (Appendix S2 for details). We
defined exposure groups according to whether the
mother and/or the father had ADHD and assessed
the risk of offspring ADHD in these groups. We
excluded individuals without information on fathers
(n = 19,264; 0.8%), of which 455 (2.4%) had mothers
with ADHD, however, we analyzed mother–offspring
ADHD recurrence risk for these mothers in a sensi-
tivity analysis.
Likewise, we assessed the risk of ADHD in off-
spring of parents registered with an ICD-10 code of
either bipolar disorder (BD; F30–F31), schizophrenia
spectrum disorder (SCZ; F20–F29), or major depres-
sive disorder (MDD; F32–F33). We defined exposure
groups based on the parental disorder as described
for ADHD, however, for these analyses parents with
ADHD were excluded. For all the exposure groups,
including parents with ADHD, parents without the
specific disorder served as the reference group.
Outcomes
In all analyses, the outcome was defined as offspring
ADHD. We analyzed the prevalence of ADHD in sons
and daughters born to parents in all the described
exposure groups and evaluated differences in preva-
lence of ADHD between offspring of parents with and
without the various disorders. We use the term
‘intergenerational recurrence risk’ as the relative
risk (RR) of ADHD in offspring by parental ADHD.
We assessed the recurrence risk for offspring born
1967–2011 (offspring age range 4–48 years, mothers
14–98 years, and fathers 15–100 years at record
linkage in 2015). In these analyses, we adjusted for
offspring year of birth only (5-year groups from 1967
to 2011, with 1967–1973 as reference period).
Statistical analyses
To evaluate offspring ADHD by parental ADHD and
other psychiatric disorders, both prevalence rates,
prevalence differences (PD) and relative risks (RR)
were calculated using predicted absolute prevalence
from a Poisson regression model with adjustment for
year of birth (5-year groups; Zou, 2004). To account
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for correlation between siblings, we used mother’s
identification number as a cluster variable in the
analyses. We also calculated the parent–offspring
recurrence of ADHD: (a) confined to first offspring
born 1967–2011, and (b) for a narrower follow-up
period, confined to offspring born 1981–2011 whose
parents were born 1967–1997, as sensitivity analy-
ses.
We examined intergenerational recurrence risks
within an epidemiological framework. Therefore, we
chose epidemiological measures of associations
(Khoury, Beaty, & Cohen, 1993). However, as a
supplementary analysis, we also calculated tetra-
choric correlations (mother–offspring and father–
offspring) as a quantification of the genetic and
environmental (familial) contributions from mother/
father to offspring.
Two-sided tests with a significance threshold of
p < .05 were used in all analyses. Analyses were
carried out with SPSS Statistics 23 (IBM Corp.
Released, 2013) and STATA intercooled version 14
(StataCorp, 2015. StataCorp LP) from October 3,
2018, to October 1, 2020.
Results
We included a total of 2,486,088 offspring born
1967–2011 and alive in 2015. A total of 79,719
offspring (37.6% females) with ADHD were identified.
Among these, 20,032 (0.8%) offspring with maternal
ADHD only, 16,952 (0.7%) offspring with paternal
ADHD only, 1,545 (0.06%) offspring where both
parents had ADHD, and 2,447,559 (98.5%) offspring
with neither paternal nor maternal ADHD were
identified (offspring age range 4–48 years at record
linkage in 2015). Mothers and fathers diagnosed
with ADHD were younger at first childbirth than
mothers without ADHD (Table S1). The prevalence of
diagnosed ADHD in our data was 2.4% in adults
(born 1967–1997), and 3.3% in children and adoles-
cents (born 1998–2011), with male:female ratio 1.5
for adult offspring and 2.5 for child offspring.
When using absolute measures, we observed a
very high adjusted prevalence of ADHD in offspring
of parents with ADHD (17.8%–33.8%, Figure 1), and
especially in sons to affected parents. When both
parents had ADHD, we found that 41.5% of sons and
25.1% of daughters were diagnosed with ADHD
(Table 1). In contrast, adjusted prevalence of off-
spring ADHD was considerably lower when parents
had BD, SCZ or MDD, although higher than in
families with unaffected parents (Figure 1; Table S5).
Also, the prevalence of offspring ADHD was more
similar across these parental disorders.
When evaluating the differences in prevalence of
offspring ADHD in families with parental ADHD
compared to unaffected parents, we found larger
prevalence differences (PDs) when only the mother
had ADHD than when only the father had ADHD
(PDmothers 21.1% (20.5–21.7); PDfathers 14.8% (14.3–
15.4); Table 1). Also, the PDs were larger for sons
than for daughters in all three exposure groups.
When we compared the intergenerational recur-
rence risks of ADHD frommothers and fathers on the
relative scale, we again found that maternal ADHD
showed stronger associations with offspring ADHD
than paternal ADHD (RRmaternal 8.4; 95% confidence
interval (CI) 8.2–8.6 vs. RRpaternal = 6.2; 6.0–6.4).
The highest intergenerational recurrence risk was
found when both parents had ADHD (RRboth = 11.7;
11.0–12.5; Table 1). In contrast to what was found
on the absolute scale where PDs were larger in sons
than daughters, parent–offspring RR was larger in
daughters than in sons both for maternal and
paternal ADHD. Maternal associations were highest
both in daughters and sons. The corresponding
results for first-born offspring only, thus excluding
correlated/dependent data, and for offspring with
younger parents, were in line with the overall results
(Tables S2–S4).
Adjusted prevalence of offspring ADHD was con-
siderably lower when parents had BD, SCZ or MDD,
although higher than in families unaffected by any of
these disorders (Figure 1; Table S5). Also, the preva-
lence of offspring ADHD was more similar across
these other parental psychiatric disorders. Further,
on the absolute scale, maternal BD and MDD
seemed to confer a higher risk than their paternal
counterparts, while for SCZ, associations did not
differ by parental sex. However, PDs for offspring
ADHD were largest when both parents were affected.
All PDs were larger for sons than daughters regard-
less of affected parent (Table S5).
Parental BD, SCZ and MDD were also associated
with increased risk of offspring ADHD on the relative
scale, with RRs of ~2.0 (Figure 2; Table S5). Relative
risks were highest when both parents had a psychi-
atric disorder (RRs 2.1–2.7, Table S5). In contrast to
the findings in families with parental ADHD, RRs of
offspring ADHD did not differ significantly between
daughters and sons in families where parents had
BD, SCZ or MDD, for example, RRdaughter 1.5 (1.4–
1.7) and RRson 1.6 (1.5–1.7) with paternal BD, and
RRson 1.9 (1.8–2.0) and RRdaughter 1.9 (1.8–2.1) with
maternal BD (Table S5).
In an additional sensitivity analysis, where we
calculated the intergenerational recurrence risk of
ADHD in offspring where information on fathers was
missing, the RRs from mothers to sons and daugh-
ters were 3.4 (95% CI, 2.7–4.3) and 5.7 (95% CI, 4.5–
7.4), respectively, slightly lower but with similar
pattern as in the previous analyses. Finally, we also
calculated the tetrachoric correlations as a quantifi-
cation of the familial contribution of ADHD from
mother and father to the child. The results showed a
stronger mother–offspring (~0.5) than father–off-
spring (~0.4) correlation, and this was true indepen-
dent of the other parent’s ADHD. The familial
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contribution from parents with other psychiatric
disorders were significantly lower (~0.1), and almost
similar from mothers and fathers (Table S6).
Discussion
In this first nationwide population-based study of
parent–offspring recurrence risk of ADHD, we found
very high prevalence rates of ADHD in offspring of
parents with ADHD, especially in sons of two affected
parents. We found stronger maternal- than paternal-
offspring associations both when using relative (RRs)
and absolute (PDs) effect measures, regardless of
offspring sex. However, on the relative scale, with an
overall 6–12-fold increased risk of ADHD in off-
spring, the largest estimate was for maternal ADHD
to daughters, while on the absolute scale, the largest
estimate was for maternal ADHD to sons. Indepen-
dent of using relative or absolute effect measures,
the strongest intergenerational associations were
found when both parents had ADHD. Prevalence
rates were also slightly higher in offspring of parents
with BD, SCZ or MDD than in offspring of unaffected
parents, but far lower than when parents had ADHD.
In families where parents had BD, SCZ or MDD, we
found an approximately doubled risk of offspring
ADHD compared to families with unaffected parents,
and the relative risk estimates did not differ between
daughters and sons. Our epidemiological findings
indicate an additional diagnostic-specific increase in
risk related to parental ADHD, which was confirmed
also by analyses of genetic contribution.
The prevalence of ADHD diagnosis in offspring of
parents diagnosed with ADHD was very high, for
Figure 1 Adjusted prevalence (%) of ADHD in offspring of parents with ADHD, schizophrenia spectrum disorder, bipolar disorder, and
major depressive disorder, in three parental exposure groups. Offspring born 1967–2011, the Medical Birth Registry of Norway.
ADHD, attention-deficit/hyperactivity disorder; BD, bipolar disorder; SCZ, schizophrenia spectrum disorder; MDD, major depressive
disorder
Table 1 Parent–offspring recurrence of ADHD in offspring (mothers and fathers to offspring born 1967–2011, the Medical Birth
Registry of Norway)
Mothers and fathers with ADHD +/ or without ADHD-
Mother / Father Mother/Father+ Mother+/Father Mother+/Father+
Total couple of parents No. (%) 2,447,559 (98.5) 16,952 (0.7) 20,032 (0.8) 1,545 (0.06)
Crude prevalences No. (%)
ADHD offspring 70,191 (2.9) 3,371 (19.9) 5,612 (28.0) 545 (35.3)
ADHD daughter 25,460 (2.1) 1,171 (14.3) 2,173 (23.1) 209 (28.1)
ADHD son 44,731 (3.6) 2,200 (25.1) 3,439 (32.3) 336 (42.0)
Adjusted prevalencesa (%,95% CI)
ADHD offspring 2.9 (2.9–2.9) 17.8 (17.3–18.3) 24.2 (23.7–24.8) 33.8 (31.7–35.9)
ADHD daughter 2.2 (2.1–2.2) 13.3 (12.9–13.7) 18.0 (17.5–18.4) 25.1 (23.6–26.7)
ADHD son 3.6 (3.5–3.6) 21.9 (21.3–22.6) 29.7 (29.0–30.3) 41.5 (39.0–44.1)
Prevalence differencea (%,95% CI)
ADHD offspring 0 (ref) 14.8 (14.3–15.4) 21.1 (20.5–21.7) 30.7 (28.4–32.9)
ADHD daughter 0 (ref) 11.1 (10.7–11.6) 15.8 (15.4–16.3) 23.0 (21.3–24.7)
ADHD son 0 (ref) 18.4 (17.7–19.1) 26.1 (25.4–26.8) 37.9 (35.2–40.7)
Relative riska (95% CI)
ADHD offspring 1.0 (ref) 6.2 (6.0–6.4) 8.4 (8.2–8.6) 11.7 (11.0–12.5)
ADHD daughter 1.0 (ref) 6.7 (6.4–7.1) 10.4 (10.0–10.8) 15.2 (13.7–16.9)
ADHD son 1.0 (ref) 5.9 (5.7–6.1) 7.4 (7.2–7.6) 10.1 (9.4–10.9)
aAdjusted for year of birth (5-year groups, from 1967 to 2011, with 1967–1973 as the reference period), CI = confidence interval.
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example, a boy born to a woman diagnosed with
ADHD and a father without ADHD has an approx-
imately one in three chance of receiving an ADHD
diagnosis himself. Further, in the group of offspring
where both parents had ADHD, 41.5% of sons and
25.1% of daughters had been diagnosed with ADHD.
The high prevalence rates of ADHD, especially in
sons, could indicate that clinicians are specifically
aware of ADHD in offspring of parents with ADHD.
However, this awareness may be directed toward
boys mainly, typically more often referred and diag-
nosed in childhood compared to girls, and a potential
underdiagnosing of girls is possible. Girls often show
a different ADHD symptom profile than boys, with
more inattentive ADHD symptoms and less exter-
nalizing behavior probably leading to this referral
bias (Rucklidge, 2010).
Although the prevalence of offspring ADHD was
slightly higher in families where parents had BD,
SCZ or MDD than in families with unaffected
parents, they were considerably lower than when
parents had ADHD. This may partially be explained
by clinicians being more aware of a possible ADHD
diagnosis in offspring when parents have ADHD, but
also by the large focus in society on ADHD among
teachers and parents who are the main source of
referrals in childhood (Rucklidge, 2010).
Associations between parental ADHD and off-
spring ADHD evaluated by RRs, were strong (Smalley
et al., 2000; Takeda et al., 2010). Our finding of a
stronger intergenerational recurrence risk from
maternal than paternal ADHD to offspring has
previously been reported in at least two clinical
studies (Faraone et al., 1995; Goos et al., 2007).
Several genetic and/or environmental mechanisms
might account for the relatively stronger influence of
mothers compared to fathers, like POE (Gustavson
et al., 2017; Harold et al., 2013; Khramtsova et al.,
2019; Zayats et al., 2015). A ‘genetic nurturing effect’
could also play a role and affect the phenotype of the
parent (Kong et al., 2018), and as such indirectly
influence the offspring differentially through paren-
tally mediated environmental effects. Martin and
colleagues found no differences in the increase of
polygenic burden in females with ADHD compared to
males with ADHD (Martin et al., 2018). However, in
register-based data they observed that siblings to
female individuals with ADHD were at higher risk of
ADHD than siblings to affected males, in line with
the putative female protective effect: This implies
that females require greater exposure to genetic and
environmental factors associated with ADHD to be
diagnosed (Jacquemont et al., 2014; Taylor et al.,
2016). An interpretation of some of the results is that
the girls who do receive an ADHD diagnosis are more
severely affected than boys, which could explain why
parental ADHD is a stronger risk factor for ADHD
diagnosed in girls. The larger familial contribution to
offspring from mothers than fathers with ADHD,
~0.5 and ~0.4, respectively, supports this interpre-
tation.
It is also possible that the stronger maternal-
offspring estimates can be explained by sex differ-
ences in health-seeking behavior, with men seeking
both somatic and mental health services less than
women (Harris et al., 2016; Smith, Braunack-Mayer,
& Wittert, 2006; Thompson et al., 2016). Thus,
ADHD in women may be detected when they seek
health care for psychiatric symptoms, or when their
children are diagnosed with ADHD, where mothers
may recognize similar symptoms in themselves (Wil-
liamson & Johnston, 2015). As ADHD in women is
less common, mothers may be especially attuned to
noticing these difficulties in their offspring, and this
may influence on the stronger recurrence risk of
ADHD from mothers.
In our study, offspring of parents with BD, SCZ or
MDD showed a more general, unspecific, and
approximately doubled risk of ADHD, compared to
the higher diagnosis-specific RR in parents with
Figure 2 Relative risk of ADHD in sons and daughters of parents with ADHD, bipolar disorder, schizophrenia spectrum disorder, and
major depressive disorder. ADHD, attention-deficit/hyperactivity disorder; BD, bipolar disorder; SCZ, schizophrenia spectrum disorder;
MDD, major depressive disorder. For parents with BD, SCZ and MDD, the ADHD diagnosis were excluded
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ADHD themselves, which ranged from 6 to 12. This
is supported by previous studies (Gottesman, Laur-
sen, Bertelsen, & Mortensen, 2010; Rasic et al.,
2014). Shared common genetic and environmental
factors between ADHD and other psychiatric disor-
ders may contribute to the elevated risk of ADHD in
offspring of parents with BD, SCZ or MDD (Pet-
tersson, D’Onofrio, & Lichtenstein, 2019; The Brain-
storm Consortium, 2018). In the Brainstorm
Consortium study, Antilla and colleagues found a
high degree of genetic correlation among many of the
psychiatric disorders studied, including ADHD, BD,
SCZ and MDD. The familial contribution from par-
ents with other psychiatric disorders were signifi-
cantly lower than from parents with ADHD. In total,
this could explain the increased risk of offspring
ADHD also in families where parents have other
major psychiatric disorders, however, our findings
indicate an additional diagnosis-specific increase in
risk related to parental ADHD.
Strengths and limitations
To our knowledge, this is the largest population-
based study on parent–offspring recurrence risk of
ADHD conducted so far. It is also the first study to
evaluate the influence of both parental and offspring
sex. The nationwide, population-based registries
with complete generational data have compulsory
notification, thus reducing selection bias. Our data
was also large enough to allow the analysis of
intergenerational recurrence risk in families where
only the mother, only the father or both parents had
ADHD, BD, SCZ or MDD.
In Norway, diagnostic assessment and pharmaco-
logical treatment of ADHD is always based on
evaluation by specialist physicians or psychologists.
We chose to identify individuals with ADHD either by
a dispensed prescription of ADHD medication (from
the NorPD) or by an ADHD diagnosis (from the NPR)
in line with previous Scandinavian register-based
research (Kendler, Ohlsson, Sundquist, & Sund-
quist, 2016; Larsson, Chang, D’Onofrio, & Lichten-
stein, 2014; Skoglund, Chen, Franck, Lichtenstein,
& Larsson, 2015), including a validation study
(Larsson et al., 2013).
Limitations include the fact that our ADHD diag-
noses were based on data from 2004–2015 (NorPD)
and 2008–2015 (NPR). Since the NorPD was estab-
lished in 2004, individuals diagnosed and treated for
ADHD exclusively before 2004, will be undetected.
Further, some individuals with ADHD will not
receive medication because of contraindications or
other causes (e.g., substance use or cardiovascular
disorders); these patients are identified in the NPR,
but from 2008 only. During 2008–2015, a total of
9,346 (23.3%) adults were registered with an ADHD
diagnosis in the NPR without receiving medication.
There may be more men with ADHD not receiving
ADHD medication due to contraindications, and this
may affect the sex differences, especially in the
period 2004–2008, when our cases are based on
dispensed ADHD medication only. Further, a Nor-
wegian report showed that ~20% of children were not
prescribed ADHD medication when diagnosed with
ADHD (2008–2015; Ørstavik et al., 2016). Therefore,
the prevalence estimates in our study are likely
somewhat lower than the true prevalence, perhaps
mostly for individuals with less severe ADHD symp-
toms. We did not use time-to-event methods (e.g.,
Cox-regression), given that the register follow-up
time is relatively short (2004–2015) compared to the
birth years of the study population (1967–2011) and
their parents.
However, most of the individuals who received a
diagnosis in adult age have likely suffered from the
disorder since early childhood. Unfortunately, we
had no information about emigration or deaths. In
the sample of younger parents to offspring born
1999–2011, the mortality was 0.6% for fathers and
0.2% for mothers. To control for the effect of
parental death, we calculated the risk of ADHD in
offspring from younger parents, parents to children
born 1999–2011. Here, we found almost similar
risk estimates and a similar pattern as in the main
analyses (Table S2). In addition, one could argue
that nonbiological fathers could influence the
stronger effect from mothers, especially related to
ADHD, however, this is found to be rare (Lar-
museau et al., 2017; Larmuseau, Matthijs, &
Wenseleers, 2016). Further, by 2015, we identified
only 15 children born in 2011 diagnosed with
ADHD, which means that some, but very few were
diagnosed with ADHD at the age of 4. However,
since we wanted to include all children diagnosed
with ADHD, even at this young age, these were also
included, in line with recent guidelines (Loe, Kakar,
& Sanders, 2020).
In conclusion, and in line with the known heri-
tability of ADHD, we have shown that parental
ADHD has a strong, diagnosis-specific association
with offspring ADHD. Moreover, a stronger mother–
offspring than father–offspring intergenerational
recurrence risk of ADHD could support a number
of etiological factors, including stronger maternal
genetic effects, a stronger effect of maternal non-
transmitted alleles, the female protective effect, and
differences in health-seeking behavior. Clinicians
working in child- and adolescent as well as adult
psychiatry should be aware of these very high
recurrence rates of ADHD in sons to affected
parents and evaluate possible diagnostic bias and
underdiagnosing of daughters. Early recognition is
important to prevent the risk of increased morbidity
associated with ADHD for both males and females.
Further research is needed to understand underly-
ing environmental and genetic causes of these
observed sex differences in intergenerational recur-
rence risk and prevalence of ADHD in affected
families.
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 ADHD is a highly heritable neurodevelopmental disorder; but the intergenerational recurrence risk patterns
of ADHD from parents to sons and daughters have not been studied.
 The present population-based intergenerational study demonstrates a stronger recurrence risk of ADHD
from mothers than from fathers, and in both cases, strongest to daughters.
 Other parental psychiatric disorders also confer increased risk of offspring ADHD, with parental sex-specific
risk patterns, but with no differences between daughters and sons.
 Clinicians working in child- and adolescent as well as adult psychiatry should be aware of the very high
prevalence of ADHD in sons to affected parents and evaluate possible diagnostic bias and underdiagnosing
of daughters.
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